Add to Favorites Newsroom RSS Share
Durham, NC USA

Our News on Newswise

Risk-Reducing Mastectomy Questioned for BRCA Mutation Carriers with Prior Ovarian Cancer

For the subset of women with BRCA mutations who have already had ovarian cancer, risk-reducing mastectomy might not be worth the price tag. New research from the Duke Cancer Institute finds that for many women in this unique group, prophylactic...
11-Jul-2017 2:30 PM EDT Add to Favorites

Large-Scale, Collaborative Effort Could Help Ease Global Hearing Loss

A team of hearing experts at Duke University School of Medicine and the Duke Global Health Institute is calling for a comprehensive, worldwide initiative to combat hearing loss.
7-Jul-2017 2:30 PM EDT Add to Favorites

Antibodies Halt Placental Transmission of CMV-Like Virus in Monkeys


Researchers from Duke University School of Medicine and Tulane National Primate Research Center report findings in monkeys that demonstrates a CMV vaccine approach that appears to be capable of protecting the animal’s fetus from infection.
5-Jul-2017 11:05 AM EDT Add to Favorites

New Antibody Appears to Re-Activate Immune System in Cancer Therapy

Adding an investigational antibody to the chemotherapy rituximab appears to restore its cancer-killing properties in certain leukemia patients with a natural resistance to the drug, according to a small, proof-of-concept study by Duke Cancer...
27-Jun-2017 9:05 AM EDT Add to Favorites

Pre-Clinical Study Suggests Parkinson’s Could Start in Gut Endocrine Cells


Duke University researchers have identified a potential new mechanism for Parkinson's disease in both mice and human endocrine cells that populate the small intestines.
8-Jun-2017 3:40 PM EDT Add to Favorites

Investigational Vaccine Protected Monkeys From HIV-Like Virus

Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an...
5-Jun-2017 10:00 AM EDT Add to Favorites

Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed

A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly significant survival...
12-Apr-2017 10:00 AM EDT Add to Favorites

Study Launched to Better Understand Real-World Impact and Progression of COPD


The MURDOCK Study, Duke Clinical Research Institute and Boehringer Ingelheim Pharmaceuticals Inc. announced today the launch of a new collaborative research effort to closely follow 850 people living with chronic obstructive pulmonary disease...
7-Apr-2017 11:00 AM EDT Add to Favorites

Our YouTube Videos

Chat now!